Cerca
Close this search box.
Ceppo probiotico

Lactobacillus reuteri ATCC PTA 4659

Aree terapeutiche
Intestino e digestione
Funzionalità
Malattia diverticolare
Studi a supporto


Petruzziello C, Migneco A, Cardone S, Covino M, Saviano A, Franceschi F, et al. Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial. Int J Colorectal Dis. 2019 Jun;34(6):1087–94.

Scopri i prodotti che lo contengono

Torna in alto